Literature DB >> 24050107

Comparison of hematocrit/hemoglobin ratios in subjects with alpha-thalassemia, with subjects having chronic kidney disease and normal subjects.

Somchai Insiripong1, Tanarat Supattarobol, Arunee Jetsrisuparb.   

Abstract

The ratio of hematocrit (Hct) to hemoglobin (Hb) in the people with normal red blood cell (RBC) morphology is generally three to one. We studied Hct/Hb ratios among patients with alpha-thalassemias (Hb H, H-CS, AEBart, AEBart-CS, EFBart and EFBart-CS diseases) diagnosed by high performance liquid chromatography, and compared them with normal subjects and with patients having anemia due to chronic kidney disease (CKD). The Hct and Hb levels were derived by automated analyzer. The means +/- SD of the Hct/Hb ratios were 3.5 +/- 0.2 (range 3.3 - 4.1), 3.0 +/- 0.1 (range 2.9 - 3.2) and 3.0 +/- 0.1 (range 2.8 - 3.2) in the alpha-thalassemia, normal and CKD groups, respectively. The mean Hct/Hb ratio in subjects with alpha-thalassemia was higher than the mean in normal subjects and in those with CKD. The Hct/Hb ratios for each genotype of the alpha-thalassemia were not different from each other. The underlying mechanisms for the higher Hct/Hb ratio among those with alpha-thalassemia are theorized to be less density and/or more hydration of a-thalassemia RBCs, more entrapment of plasma in the spun RBC, the high percent of nucleated RBC and WBC interference. A ratio of 3.5 +/- 0.2 may be helpful in cases of moderate anemia when typing only shows Hb A and E, to consider investigation for alpha-thalassemia, or in cases of alpha-thalassemia with acute blood loss, if the Hct is less than 35%, in the decision to transfuse.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24050107

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Hematocrit to hemoglobin ratio as a prognostic marker in polycythemia vera.

Authors:  Ivan Krečak; Marko Lucijanić; Ivan Zekanović; Hrvoje Holik; Martina Morić Perić; Marijana Šupe; Božena Coha; Velka Gverić-Krečak
Journal:  Wien Klin Wochenschr       Date:  2021-11-04       Impact factor: 1.704

2.  A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI.

Authors:  Antonio M Chiarelli; Michael Germuska; Hannah Chandler; Rachael Stickland; Eleonora Patitucci; Emma Biondetti; Daniele Mascali; Neeraj Saxena; Sharmila Khot; Jessica Steventon; Catherine Foster; Ana E Rodríguez-Soto; Erin Englund; Kevin Murphy; Valentina Tomassini; Felix W Wehrli; Richard G Wise
Journal:  J Cereb Blood Flow Metab       Date:  2022-02-02       Impact factor: 6.960

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.